<code id='F3357562DD'></code><style id='F3357562DD'></style>
    • <acronym id='F3357562DD'></acronym>
      <center id='F3357562DD'><center id='F3357562DD'><tfoot id='F3357562DD'></tfoot></center><abbr id='F3357562DD'><dir id='F3357562DD'><tfoot id='F3357562DD'></tfoot><noframes id='F3357562DD'>

    • <optgroup id='F3357562DD'><strike id='F3357562DD'><sup id='F3357562DD'></sup></strike><code id='F3357562DD'></code></optgroup>
        1. <b id='F3357562DD'><label id='F3357562DD'><select id='F3357562DD'><dt id='F3357562DD'><span id='F3357562DD'></span></dt></select></label></b><u id='F3357562DD'></u>
          <i id='F3357562DD'><strike id='F3357562DD'><tt id='F3357562DD'><pre id='F3357562DD'></pre></tt></strike></i>

          Home / explore / hotspot

          hotspot


          hotspot

          author:knowledge    Page View:4
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In